Response to dual blockade of epidermal growth factor receptor (EGFR) and cycloxygenase-2 in nonsmall cell lung cancer may be dependent on the EGFR mutational status of the tumor

Cancer (2007) - Comments
pubmed: 17948911 doi: 10.1002/cncr.23100 issn: 0008-543x

Shirish M. Gadgeel, Shadan Ali, Philip A. Philip, Fakhara Ahmed, Antoinette Wozniak, Fazlul H. Sarkar